We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Sign In
Create Account
Sign Out
My Account
Home
»
Store
» Generic Line
Search the Store
Shop By Category
Drug Products
Drug Books
Device Products
Device Books
Clinical Products
Shop By Media
Books
Webinar Recordings
Generic Line
-- Sort By --
New Arrivals
Best Sellers
Price: Low to High
Price: High to Low
A to Z
Court Invalidates Cubicin Patents, Opening the Door to Generics
Price:
$40.00
Learn More
FDA Establishes Meetings Framework for Biosimilars Application Holders
Price:
$40.00
Learn More
FDA Cites Generics Maker Heritage Over Postmarket Reporting Woes
Price:
$40.00
Learn More
Court Opens Door to Generic Benicar by Refusing Patent Cases
Price:
$40.00
Learn More
FTC Says Pay-for-Delay Violations Not Contingent on Regulatory Action
Price:
$40.00
Learn More
Allergan Asks Court to Overturn Mandatory Production Injunction
Price:
$40.00
Learn More
Federal District Court Imposes TRO On Generic Nexium Over Coloration
Price:
$40.00
Learn More
Robert Califf Fends Off Senators’ Questions on Generics, Biosimilars During Hearing
Price:
$40.00
Learn More
Panelists Say Biosimilars Market Needs Regulatory and Patent Changes to Grow
Price:
$40.00
Learn More
FTC OKs Mylan-Perrigo Deal, Demands Sale of Seven Generics
Price:
$40.00
Learn More
Hospira Prepares Second Biosimilar Application After FDA Rejects First
Price:
$40.00
Learn More
Health Canada Formally Retracts Import Ban on Indian Apotex Products
Price:
$40.00
Learn More
Previous
1
2
3
4
5
6
7
8
9
…
21
22
Next